Tempus AI launches effort to build 100,000 whole-genome dataset linked to clinical outcomes

Tempus set a long-term goal to expand the platform to 1 million genomes.

Initial access is available via an Early Adopter Program, with general availability targeted for mid-2027.

Tempus AI launched an initiative to build a research platform of 100,000 disease-specific whole-genome sequences linked to longitudinal clinical outcomes.

The company said the project targets AI-driven research, positioning the dataset as model-ready within its de-identified multimodal data environment.